Analyzing the Latest Novocure 10-K Filing

August 15. 2023. 6 mins read

Ever get annoyed when people ask you for money to cure breast cancer? We do too, but it’s not just because another one of the 1.5 million charities in the United States wants access to our wallet. Never mind there are more than 200 types of cancer, or that each person’s cancer is unique and needs to be treated as such. It’s because we already have a cure for most breast cancer occurrences, something we covered in our piece on Early Detection of Breast Cancer Cures Breast Cancer. Making sure all women are going through regular screenings goes a lot further than peddling pink ribbons on the high street.

A device that helps treat cancer is an intuitive investment thesis because we all know someone that’s been affected by the big “C.” Today, we’re going to talk about a company that’s involved in treating cancer called Novocure (NVCR). The only piece of collateral we’re using for this piece is their latest 10-K filing. This is to show investors how a 10-K can be effectively used to analyze any company.

What Does Novocure Do?

“What’s a 10-K?” some of you might ask. Good question. Make sure you click this link and subscribe to the Nanalyze YouTube channel as we’ll be dropping an instructional video shortly that shows you how to find a 10-K for any company a

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.